7. Juni 2024 – Following the entry into force of the revised Therapeutic Products Act, Swissmedic published additional information of general interest relating to therapeutic products. In its SwissPAR Swissmedic summarizes evaluations of new human medicinal and transplant products, as well as additional indications for approved products. The report, released in English, is tailored for healthcare professionals, industry representatives, and authorities, excluding proprietary or personal data of the applicants.

For more information, see here.